相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glycogen synthase kinase 3 is part of the molecular machinery regulating the adaptive response to LPS stimulation in microglial cells
Maria Antonietta Ajmone-Cat et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Neurodevelopmental origins of bipolar disorder: iPSC models
K. Sue O'Shea et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2016)
The effect of lithium on hematopoietic, mesenchymal and neural stem cells
Ewa Ferensztajn-Rochowiak et al.
PHARMACOLOGICAL REPORTS (2016)
Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers
Ather Muneer
PSYCHIATRY INVESTIGATION (2016)
Staging Models in Bipolar Disorder: A Systematic Review of the Literature
Ather Muneer
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2016)
Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism
Andrea de Bartolomeis et al.
CNS DRUGS (2015)
Cellular models to study bipolar disorder: A systematic review
Biju Viswanath et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
Circadian Rhythmicity of Active GSK3 Isoforms Modulates Molecular Clock Gene Rhythms in the Suprachiasmatic Nucleus
Rachel C. Besing et al.
JOURNAL OF BIOLOGICAL RHYTHMS (2015)
Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders
Guido Furlotti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Lithium increases platelet serine-9 phosphorylated GSK-3β levels in drug-free bipolar disorder during depressive episodes
Rafael T. de Sousa et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalities
J. M. Madison et al.
MOLECULAR PSYCHIATRY (2015)
Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease
Mojtaba Golpich et al.
PHARMACOLOGICAL RESEARCH (2015)
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Eleonore Beurel et al.
PHARMACOLOGY & THERAPEUTICS (2015)
FXR1P is a GSK3β substrate regulating mood and emotion processing
Thomas Del'Guidice et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Region-specific dysregulation of glycogen synthase kinase-3β and β-catenin in the postmortem brains of subjects with bipolar disorder and schizophrenia
Ghanshyam N. Pandey et al.
BIPOLAR DISORDERS (2015)
Ankyrin-G regulates neurogenesis and Wnt signaling by altering the subcellular localization of β-catenin
O. Durak et al.
MOLECULAR PSYCHIATRY (2015)
Loss of neuronal GSK3 beta reduces dendritic spine stability and attenuates excitatory synaptic transmission via beta-catenin
S. M. Ochs et al.
MOLECULAR PSYCHIATRY (2015)
Wnt and lithium: a common destiny in the therapy of nervous system pathologies?
Delphine Meffre et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Signaling Pathways Involved in Antidepressant-Induced Cell Proliferation and Synaptic Plasticity
Fuencisla Pilar-Cuellar et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
mTOR regulates brain morphogenesis by mediating GSK3 signaling
Minhan Ka et al.
DEVELOPMENT (2014)
Genome-wide association study of bipolar disorder accounting for effect of body mass index identifies a new risk allele in TCF7L2
S. J. Winham et al.
MOLECULAR PSYCHIATRY (2014)
Wnt signaling in neuropsychiatric disorders: Ties with adult hippocampal neurogenesis and behavior
Syed Mohammed Qasim Hussaini et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2014)
Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia
Adam R. Cole
FEBS JOURNAL (2013)
Altered Wnt signalling in the teenage suicide brain: focus on glycogen synthase kinase-3β and β-catenin
Xinguo Ren et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK-3 activities
Chien-Yu Kao et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Genetic and clinical factors predict lithium's effects on PER2 gene expression rhythms in cells from bipolar disorder patients
M. J. McCarthy et al.
TRANSLATIONAL PSYCHIATRY (2013)
A genome-wide association study of attempted suicide
V. L. Willour et al.
MOLECULAR PSYCHIATRY (2012)
Lithium-induced effects on adult hippocampal neurogenesis are topographically segregated along the dorso-ventral axis of stressed mice
Olivia F. O'Leary et al.
NEUROPHARMACOLOGY (2012)
DISRUPTION OF CIRCADIAN RHYTHMICITY AND SUPRACHIASMATIC ACTION POTENTIAL FREQUENCY IN A MOUSE MODEL WITH CONSTITUTIVE ACTIVATION OF GLYCOGEN SYNTHASE KINASE 3
J. R. Paul et al.
NEUROSCIENCE (2012)
Potential opposite roles of the extracellular signal-regulated kinase (ERK) pathway in autism spectrum and bipolar disorders
Hans O. Kalkman
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2012)
Akt/PKB Controls the Activity-Dependent Bulk Endocytosis of Synaptic Vesicles
Karen J. Smillie et al.
TRAFFIC (2012)
GSK-3 and Wnt signaling in neurogenesis and bipolar disorder
Alexander J. Valvezan et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2012)
Neuronal migration, apoptosis and bipolar disorder
Ezequiel Uribe et al.
REVISTA DE PSIQUIATRIA Y SALUD MENTAL (2012)
Identification of a Glycogen Synthase Kinase-3β Inhibitor that Attenuates Hyperactivity in CLOCK Mutant Mice
Alan P. Kozikowski et al.
CHEMMEDCHEM (2011)
Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania
Mikhail Kalinichev et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Glycogen synthase kinase-3 is essential for β-arrestin-2 complex formation and lithium-sensitive behaviors in mice
W. Timothy O'Brien et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
HDAC6 Regulates LPS-Tolerance in Astrocytes
Eleonore Beurel
PLOS ONE (2011)
Glycogen synthase kinase-3 in the etiology and treatment of mood disorders
Richard Scott Jope
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Synaptic Plasticity in the Pathophysiology and Treatment of Bipolar Disorder
Jing Du et al.
BEHAVIORAL NEUROBIOLOGY OF BIPOLAR DISORDER AND ITS TREATMENT (2011)
Regulation of glycogen synthase kinase-3 during bipolar mania treatment
Xiaohong Li et al.
BIPOLAR DISORDERS (2010)
A haplotype of glycogen synthase kinase 3β is associated with early onset of unipolar major depression
E. Saus et al.
GENES BRAIN AND BEHAVIOR (2010)
Deficiency in the Inhibitory Serine-Phosphorylation of Glycogen Synthase Kinase-3 Increases Sensitivity to Mood Disturbances
Abigail Polter et al.
NEUROPSYCHOPHARMACOLOGY (2010)
The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis
Rodrigo Machado-Vieira et al.
BIPOLAR DISORDERS (2009)
Evidence for Selective microRNAs and Their Effectors as Common Long-Term Targets for the Actions of Mood Stabilizers
Rulun Zhou et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signalling pathway
N. Matigian et al.
MOLECULAR PSYCHIATRY (2007)
Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3β in ventral prefrontal cortex of depressed suicide victims
Felicien Karege et al.
BIOLOGICAL PSYCHIATRY (2007)
Targeting glycogen synthase kinase-3 as an approach to develop novel mood-stabilising medications
Todd D. Gould
EXPERT OPINION ON THERAPEUTIC TARGETS (2006)
Glycogen synthase kinase-3β, mood stabilizers, and neuroprotection
XH Li et al.
BIPOLAR DISORDERS (2002)
分享论文
